Midatech Pharma plc
MTPNASDAQHealthcare
$0.29
$-0.06(-18.50%)
Market Cap$1976846
P/E Ratio—
52W High$20.8
52W Low$0.19
Midatech Pharma plc (MTP) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
MTP · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2024Report Date: Jun 30, 2024EPS Actual
-$6.38
Revenue
—
Fiscal Period
Q2 FY2024
FY ends December
Report Date
Jun 30, 2024
After Market Close
MTP reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| — Q2 FY2024 | Jun 30, 2024 | — | -$6.38 | — | — | — | — |
| — Q1 FY2024 | Mar 31, 2024 | — | -$6.33 | — | — | — | — |
| — Q4 FY2023 | Dec 31, 2023 | — | -$41.67 | — | $0.00B | — | — |
| — Q3 FY2023 | Sep 30, 2023 | — | -$1.60 | — | $0.00B | — | — |
| — Q2 FY2023 | Jun 30, 2023 | — | -$9.11 | — | $0.00B | — | — |
| — Q2 FY2023 | Apr 25, 2023 | — | -$8.89 | — | $0.00B | — | — |
| — Q4 FY2022 | Dec 31, 2022 | — | -$227.76 | — | $0.00B | — | — |
| — Q3 FY2022 | Sep 30, 2022 | — | -$205.02 | — | $0.00B | — | — |
Q2 FY2024
Jun 30, 2024
EPS Actual
-$6.38
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2024
Mar 31, 2024
EPS Actual
-$6.33
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2023
Dec 31, 2023
EPS Actual
-$41.67
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2023
Sep 30, 2023
EPS Actual
-$1.60
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2023
Jun 30, 2023
EPS Actual
-$9.11
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2023
Apr 25, 2023
EPS Actual
-$8.89
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2022
Dec 31, 2022
EPS Actual
-$227.76
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2022
Sep 30, 2022
EPS Actual
-$205.02
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
No analyst estimates available for MTP.
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q2 FY2024 | Jun 30, 2024 | — | $0.13 | — | — |
| — Q1 FY2024 | Mar 31, 2024 | — | $0.13 | — | — |
| — Q4 FY2023 | Dec 31, 2023 | — | $0.13 | — | — |
| — Q3 FY2023 | Sep 30, 2023 | — | $0.13 | — | — |
| — Q2 FY2023 | Jun 30, 2023 | — | $0.13 | — | — |
| — Q2 FY2023 | Apr 25, 2023 | — | $0.27 | $0.24 | -9.40% |
| — Q4 FY2022 | Dec 31, 2022 | — | $0.99 | $0.95 | -3.56% |
| — Q3 FY2022 | Sep 30, 2022 | — | $1.92 | $1.86 | -3.20% |
Q2 FY2024—
Report Date
Jun 30, 2024
EPS Beat/Miss
—
Price Before
$0.13
Price After
—
Q1 FY2024—
Report Date
Mar 31, 2024
EPS Beat/Miss
—
Price Before
$0.13
Price After
—
Q4 FY2023—
Report Date
Dec 31, 2023
EPS Beat/Miss
—
Price Before
$0.13
Price After
—
Q3 FY2023—
Report Date
Sep 30, 2023
EPS Beat/Miss
—
Price Before
$0.13
Price After
—
Q2 FY2023—
Report Date
Jun 30, 2023
EPS Beat/Miss
—
Price Before
$0.13
Price After
—
Q2 FY2023-9.40%
Report Date
Apr 25, 2023
EPS Beat/Miss
—
Price Before
$0.27
Price After
$0.24
Q4 FY2022-3.56%
Report Date
Dec 31, 2022
EPS Beat/Miss
—
Price Before
$0.99
Price After
$0.95
Q3 FY2022-3.20%
Report Date
Sep 30, 2022
EPS Beat/Miss
—
Price Before
$1.92
Price After
$1.86
Beat Rate0 / 8 quarters
Largest Move-9.40% (Q2 FY2023)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: MTP ends December
Midatech Pharma plc (MTP) most recently reported earnings on June 30, 2024 for Q2 FY2024, posting EPS of $-6.38 (in line with the analyst consensus of —). The next MTP earnings date is expected around September 1, 2026.
Each quarter, investors track MTP earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. MTP revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
MTP's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
MTP earnings · 4 questionsMidatech Pharma plc's next earnings report is expected around September 1, 2026. MTP typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; MTP historically reports after market close (AMC).
MTP earnings datewhen is MTP earningsMTP next earnings datewhen does MTP report earningsMTP earnings calendar
▸ Source: FMP · Midatech Pharma plc SEC filings · US GAAP · Midatech Pharma plc SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026